|
C18ORF45 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13350000496837E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.376810E-04 |
| Normal-vs-Stage2 |
7.377300E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
7.003400E-03 |
| Stage1-vs-Stage2 |
6.609600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.516400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.651600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28220000172874E-08 |
| Normal-vs-AfricanAmerican |
4.877400E-01 |
| Normal-vs-Asian |
1.680760E-01 |
| Caucasian-vs-AfricanAmerican |
1.611630E-01 |
| Caucasian-vs-Asian |
4.009200E-01 |
| AfricanAmerican-vs-Asian |
2.444200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.60060000000373E-05 |
| Normal-vs-Female |
6.22149999999211E-05 |
| Male-vs-Female |
9.529800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.820300E-03 |
| Normal-vs-Extreme_Weight |
6.49129999999998E-05 |
| Normal-vs-Obese |
1.418230E-03 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
2.197800E-01 |
| Normal_Weight-vs-Obese |
1.690180E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.263400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.512000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.478300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.20529999999108E-05 |
| Normal-vs-Age(81-100Yrs) |
5.176600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.945400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.227000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.106000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.346600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.009200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.418600E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
8.325600E-01 |
| Normal-vs-Grade 3 |
7.591800E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
9.733200E-01 |
| Grade 2-vs-Grade 4 |
8.325600E-01 |
| Grade 3-vs-Grade 4 |
7.591800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.97289999995343E-06 |
| Normal-vs-N1 |
7.359400E-03 |
| N0-vs-N1 |
2.584800E-01 |
|
|
